Slate Bio
slatebio.com
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$7.6M
3 rounds on record
Latest round
$2.8M
Venture round · Dec 2022 · 3 yr ago
Team
11-50
employees, estimated range
Backers
1
Epidarex Capital
The money's age
Long since its last round
44 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 30, 2022
Raised a round Venture round $2.8M · SEC Form D
Dec 30, 2022
Raised a round Venture round $2.8M · SEC Form D
Dec 24, 2020
Raised a round Venture round $2M · SEC Form D
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Dec 2022 | $2.8M | — | SEC Form D |
| Venture round | Dec 2022 | $2.8M | — | SEC Form D |
| Venture round | Dec 2020 | $2M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Slate Bio, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Kurt WoerpelExecutive OfficerSEC Form D
Andrew KrouseExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Epidarex Capital Similar startupsby what they do, their industry and backers
Transforming the field of immune tolerance with a novel antigen-specific and targeted nanoparticle technology. Topas Therapeutics is…
Ditto Bio discovers drugs for autoimmune diseases by harnessing parasite biology.
Precision therapy for autoimmune-driven diseases is now within reach. Current treatments for autoimmune diseases are non-specific, often…
Oblenio Bio is pursuing broad immune reset as a transformative therapy for refractory autoimmune diseases through our LBL-051 T-cell…
On a mission to transform the future of autoimmune care. Developing innovative therapies with the potential to redefine the standard of…
Committed to developing high-impact and differentiated therapies, with a focus on building a robust autoimmune disease and cancer pipeline…
Overview
Advanced Treg Therapy for Autoimmune Diseases. For more information, contact [email protected].
People
Kurt Woerpel
Executive Officer
Andrew Krouse
Executive Officer, Director
Robert Creeden
Director
Kyparissia Sirinakis
Director
Brian Gallagher
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Charlottesville
United States
HQ
10-50 est. staff